Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax

Candoni A.;Lazzarotto D.;Papayannidis C.;Piccini M.;Nadali G.;Dargenio M.;Riva M.;Fracchiolla N.;Mellillo L.;Dragonetti G.;Del Principe M. I.;Cattaneo C.;Stulle M.;Pasciolla C.;De Marchi R.;Delia M.;Tisi M. C.;Bonuomo V.;Sciume M.;Spadea A.;Sartor C.;Griguolo D.;Buzzatti E.;Basilico C. M.;Sarlo C.;Piccioni A. L.;Cerqui E.;Lessi F.;Olivieri A.;Fanin R.;Luppi M.;Pagano L.

2023-01-01